Therapeutic experience of Bing-Neel syndrome associated with Waldenstrom's macroglobulinemia

Journal of Korean Medical Science

Volumn 22, Issue 6, 2007, Pages 1079-1081

  Hyun, Do Kim ^a   Kyeong, Cheol Shin ^a   Hee, Soon Cho ^a   Kim, Min Kyoung ^a   Kyung, Hee Lee ^a   Myung, Soo Hyun ^a  

^a Yeungnam University College of Medicine   (South Korea)

Author keywords

Central nervous system; Waldenstrom's macroglobulinemia

Indexed keywords

DRUG DERIVATIVE; FLUDARABINE; MONOCLONAL ANTIBODY; RITUXIMAB; VIDARABINE;

ARTICLE; BRAIN; CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASE; FEMALE; HUMAN; MIDDLE AGED; PATHOLOGY; SKULL IRRADIATION; SYNDROME; WALDENSTROEM MACROGLOBULINEMIA;

ANTIBODIES, MONOCLONAL; BRAIN; CENTRAL NERVOUS SYSTEM DISEASES; CRANIAL IRRADIATION; FEMALE; HUMANS; MIDDLE AGED; SYNDROME; VIDARABINE; WALDENSTROM MACROGLOBULINEMIA;

EID: 38349105875     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2007.22.6.1079     Document Type: Article

References (20)

1. Waldenstrom J. Incipient myelomatosis or "essential" hyperglobulinemia with fibrinogenopenia-a new syndrome? Acta Med Scand 1944; 117: 216-22.
2. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. Ann Oncol 1999; 10: 1419-32.
3. Dimopoulos MA, Alexanian R. Waldenstrom's macroglobulinemia, Blood 1994; 83: 1452-9.
4. Civit T, Coulbois S, Baylac F, Auque J. Waldenstrom's macroglobulinemia and cerebral lymphoplasmocytic proliferation: Bing and Neel syndrome. Apropos of a new case. Neurochirurgie 1997; 43: 245-9.
5. Bing J, Neel A. Two case of hyperglobulinemia with affection of the central nervous system on a toxi-infection basis. Acta Med Scand 1936; 88: 492-506.
6. Waldenström J. Incipient myelomatosis or "essential" hyperglobulinemia with fibrinogenopenia-a new syndrome? Acta Me Scand 1944; 117: 216-47.
7. Scheithauer BW, Rubinstein LJ, Herman MM. Leukoencephalopathy in Waldenstrom's macroglobulinemia: immunohistochemical and electron microscopic observations. J Neuropathol Exp Neurol 1984; 43: 408-25.
8. Edgar R, Dutcher TF. Histopathology of the Bing-Neel syndrome. Neurology 1961; 11: 239-45.
9. Imai F, Fujisawa K, Kiya N, Ninomiya T, Ogura Y, Mizoguchi Y, Sano H, Kanno T. Intracerebral infiltration by monoclonal plasmacytoid cells in Waldenstrom's macroglobulinemia-case report. Neurol Med Chir (Tokyo) 1995; 35: 575-9.
10. Logothetis J, Silverstein P, Coe J. Neurologic aspects of Waldernstrom's macroglobulinemia: report of a case. Arch Neurol 1960; 3: 564-73.
11. Tommasi M, Revol L, Schott B, Lesbros F. Waldenstrom's macroglobulinemia. Lesions of the central nervous system. Ann Anat Pathol (Paris) 1966; 11: 309-13.
12. Case Records of the Massachussetts General Hospital (Case 8-2001). N Engl J Med 2001; 344: 832-9.
13. Leger JM, Younes-chennoufi AB, Zuber M, Bouche P, Jauberteau MO, Dormont D, Danon F, Baumann N, Brunet P. Frequency of central lesions in polyneuropathy associated with IgM monoclonal gammopathy: an MRI, Neurophysiological and immunochemical study. J Neurol Neurosurg Psychiatry 1992; 55: 112-5.
14. Neau JP, Guilhot F, Dumas P, Besson I, Rivasseau-Jonveaux T, Gil R. Central nervous system involvement in Waldenstrom's disease. Bing-Neel syndrome. 3 cases. Rev Neurol (Paris) 1991; 147: 56-60.
15. Torrey JJ, Katakkar SB. Treatable meningeal involvement in Waldenstrom's macroglobulinemia. Ann Intern Med 1984; 101: 345-7.
16. Kohli CM, Kawazu T. Solitary intracranial plasmacytoma. Surg Neurol 1982; 17: 307-12.
17. Richards AI. Response of meningeal Waldenstrom's macroglobulinemia to 2-chlorodeoxyadnosine. J Clin Oncol 1995; 13: 2476.
18. Delgado J, Canales MA, Garcia B, Alvarez-Ferreira J, Garcia-Grande A, Hernandez-Navarro F. Radiation therapy and combination of cladribine, cyclophosphamide, and prednisone as treatment of Bing-Neel syndrome: case report and review of the literature. Am J Hematol 2002; 69: 127-31.
19. Dimopoulos MA, Zervas C, Zomas A, Kiamouris C, Viniou NA, Grigoraki V, Karkantaris C, Mitsouli C, Gika D, Christakis J, Anagnostopoulos N. Treatment of Waldenstrom's macroglobulinemia with rituximab. J Clin Oncol 2002; 20: 2327-33.
20. Monson NL, Cravens PD, Frohman EM, Hawker K, Racke MK. Effect of rituximab on the peripheral blood and cerebrospinal fluid B cells in patients with primary progressive multiple sclerosis. Arch Neurol 2005; 62: 258-64.